Carbamazepine inhibits angiotensin I-converting enzyme, linking it to the pathogenesis of temporal lobe epilepsy

@inproceedings{Almeida2012CarbamazepineIA,
  title={Carbamazepine inhibits angiotensin I-converting enzyme, linking it to the pathogenesis of temporal lobe epilepsy},
  author={Sebasti{\~a}o Sousa Almeida and Maria da Graça Naffah-Mazzacoratti and Paola Bianchi Guimar{\~a}es and Frederick Wasinski and Frances E. Pereira and Mauro Canzian and Ricardo da Silva Centeno and Henrique H. Carrete and Elza M.T. Yacubian and Adriana Karaoglanovich Carmona and Renata de Freitas Fischer Vieira and Cl{\'o}vis Ryuichi Nakaie and Regiane Ang{\'e}lica Sabatini and Sandra Regina Perosa and Reury Frank Pereira Bacurau and Telma Luciana Furtado Gouveia and Guillermo Gallo and Martin W{\"u}rtele and Esper Abr{\~a}o Cavalheiro and Julia de Almeida Silva and Jo{\~a}o Bosco Pesquero and Ronaldo C Araujo},
  booktitle={Translational Psychiatry},
  year={2012}
}
We find that a common mutation that increases angiotensin I-converting enzyme activity occurs with higher frequency in male patients suffering from refractory temporal lobe epilepsy. However, in their brains, the activity of the enzyme is downregulated. As an explanation, we surprisingly find that carbamazepine, commonly used to treat epilepsy, is an inhibitor of the enzyme, thus providing a direct link between epilepsy and the renin–angiotensin and kallikrein–kinin systems. 
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS

From This Paper

Figures, tables, and topics from this paper.

References

Publications referenced by this paper.
Showing 1-10 of 17 references

of humans with temporal lobe epilepsy

N Takahashi, Hagaman, HS Kim, O Smithies
2007

Is angiotensin-II an endogenous pro-inflammatory molecule?

Medical science monitor : international medical journal of experimental and clinical research • 2005
View 1 Excerpt

Similar Papers

Loading similar papers…